Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hesperetin Rescues Amyloid Beta-Induced Defects in Neurite Outgrowth Under <i>In Vitro</i> Mild Cognitive Impairment-like Cellular Conditions.

International journal of molecular sciences·2026
Same author

Effect of Paroxetine or Escitalopram Coadministered with Oxycodone versus Oxycodone Alone on Ventilation during Hypercapnia: A Randomized Clinical Trial.

Anesthesiology·2026
Same author

Proteomic Identification of Plasma Biomarkers of Response to IL-5 Inhibitor Biologics in Healthy Subjects.

Clinical and translational science·2025
Same author

Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential.

Journal of cardiovascular development and disease·2025
Same author

Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation.

The Journal of pharmacology and experimental therapeutics·2025
Same author

Assessment of drug permeability using a small airway microphysiological system.

Frontiers in pharmacology·2025

相关实验视频

Updated: Jun 23, 2025

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

1.8K

使用对齐的人类iPSC衍生的心肌细胞进行收缩性评估.

Ayano Satsuka1, Alexandre J S Ribeiro2, Hiroyuki Kawagishi1

  • 1Division of Pharmacology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan.

Journal of pharmacological and toxicological methods
|June 25, 2024
PubMed
概括
此摘要是机器生成的。

在纳米模式板上对齐的人类诱导多能干细胞衍生的心肌细胞 (hiPSC-CMs) 显示了改善的收缩性和药物反应. 这种增强的模型为在药物开发过程中评估药物诱导的心脏收缩功能障碍提供了更好的方法.

关键词:
调整 调整 调整一个心肌细胞.契约性 契约性是指契约性.人类iPS细胞细胞.图像成像是一种成像.运动分析运动分析.新方法方法论新方法方法论安全评估安全评估安全评估

更多相关视频

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

2.8K
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

13.1K

相关实验视频

Last Updated: Jun 23, 2025

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

1.8K
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

2.8K
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

13.1K

科学领域:

  • 心血管研究研究心血管研究
  • 干细胞生物学 干细胞生物学
  • 药物开发与毒理学 药物开发与毒理学

背景情况:

  • 心脏安全性,包括心律失常和收缩性,在药物开发中至关重要.
  • 人类诱导的多能干细胞衍生心肌细胞 (hiPSC-CMs) 对于预测前节律风险非常有价值.
  • 使用hiPSC-CMs评估药物诱导的收缩功能障碍需要进一步细化.

研究的目的:

  • 调查纳米图案板上的对齐的hiPSC-CM是否可以改善与非对齐培养相比,对药物诱导的收缩变化的评估.
  • 评估对齐的hiPSC-CMs的结构和功能特性,用于心脏安全测试.

主要方法:

  • 在纳米图案板上培养的hiPSC-CMs (对齐) 与普通板 (不对齐).
  • 使用下一代测序和qPCR进行基因表达分析.
  • 使用基于图像的运动分析系统评估心肌细胞收缩性.

主要成果:

  • 对齐的hiPSC-CMs显示了对齐的形态和关键的收缩性相关基因的增强表达.
  • 对齐的hiPSC-CMs显示收缩和放松速度增加.
  • 对齐的hiPSC-CMs对异型药物如异型醇和维拉帕米尔有更多的生理反应.

结论:

  • 对齐的hiPSC-CM具有用于收缩性评估的增强结构和功能特性.
  • 这种对齐的hiPSC-CM模型改善了药物诱导的心脏收缩功能障碍的评估.
  • 纳米模式基板为基于hiPSC-CM的先进药物安全测试提供了一个有前途的平台.